Medisca Off Script

What role will peptides, quality and artificial intelligence play in the future of pharmaceutical compounding?

In Part 2 of Medisca Off Script, Founder & CEO Antonio Dos Santos continues his conversation with CCO Charlie Guerini, exploring the importance of peptide education, the introduction of Medisca Quality (MQ) and the emerging opportunities shaping personalized medicine.

From advancing quality standards and navigating regulatory challenges to the potential of AI in formulation development and patient care, hear firsthand perspectives on the innovations, responsibilities and opportunities ahead for the compounding industry.

Explore more

Medisca Off Script: https://www.medisca.com/medisca-off-script-podcast

Medisca: https://www.medisca.com

What will define the next decade of pharmaceutical compounding? 

In the premiere episode of Medisca Off Script, our Founder & CEO Antonio Dos Santos joins CCO Charlie Guerini to explore the evolution of compounding, the growing momentum behind peptides and why quality, innovation and regulatory change will shape the future of personalized medicine 

From industry challenges to emerging opportunities, hear firsthand perspectives on what it will take to move compounding forward

Explore more

Medisca Off Script: https://www.medisca.com/medisca-off-script-podcast

Medisca: https://www.medisca.com